NCT04628676

Brief Summary

The primary aim of this report is to determine whether there is a difference between Epinephrine and Tranexamic acid in providing visual clarity during arthroscopic rotator cuff tear repair.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2017

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2020

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

October 29, 2020

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 13, 2020

Completed
Last Updated

November 13, 2020

Status Verified

November 1, 2020

Enrollment Period

2.9 years

First QC Date

October 29, 2020

Last Update Submit

November 12, 2020

Conditions

Keywords

shoulder arthroscopyirrigationepinephrineimage qualitytranexamic acidcuff tear repairvisual clarity

Outcome Measures

Primary Outcomes (1)

  • Visual analog scale

    Visual analog scale will be rated by surgeon. While 0 is the worst score with no clear vision, 10 was noted as the best score for visual clarity.

    through study completion, an average of 2 year

Secondary Outcomes (2)

  • total operating time

    through study completion, an average of 2 year

  • average mean arterial pressure

    through study completion, an average of 2 year

Study Arms (2)

TXA group

EXPERIMENTAL

tranexamic acid added to irrigation solution

Drug: tranexamic acid

EPN group

EXPERIMENTAL

epinephrine added to irrigation solution

Drug: Epinephrine

Interventions

Tranexamic acid is added to the irrigation fluid used in arthroscopic shoulder surgery.

Also known as: TRANSAMINE %5 5 ml 250 mg
TXA group

Epinephrine is added to the irrigation fluid used in arthroscopic shoulder surgery.

Also known as: ADRENALIN 0,5 mg/1 m
EPN group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years
  • American Society of Anesthesiologist Physical Status Classification System : 1-2
  • Undergoing a full arthroscopic double-row repair due to full-thickness cuff tear
  • Being willing to participate the study

You may not qualify if:

  • Age \< 18 years
  • American Society of Anesthesiologist Physical Status Classification System ≥3
  • Concomitant cardiac diseases
  • Concomitant bleeding disorder or coagulopathy
  • Diabetes mellitus
  • Being pregnant
  • Use of contraceptive pills
  • A history of previous shoulder surgery
  • Uncontrolled hypertension during the operation (\>180/110 mm Hg)
  • Unrepairable rotator cuff tears
  • Being unwilling to participate the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haseki Training and Research Hospital

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Rotator Cuff Injuries

Interventions

Tranexamic AcidEpinephrine

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon Injuries

Intervention Hierarchy (Ancestors)

Cyclohexanecarboxylic AcidsAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsEthanolaminesAmino AlcoholsAlcoholsAminesBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
medical doctor

Study Record Dates

First Submitted

October 29, 2020

First Posted

November 13, 2020

Study Start

February 1, 2017

Primary Completion

December 30, 2019

Study Completion

January 30, 2020

Last Updated

November 13, 2020

Record last verified: 2020-11

Locations